HAVCR2 and neoplasm: Recent studies have highlighted novel associations with immune checkpoints proteins that could be useful such as LAG3, TIM3, or TIGIT (Karlsson et al. 2020; Durante et al. 2020; Lin et al. 2021) due to their expression levels within tumours.